This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
SCRIP
  • Menu
  • Articles
    • Case Report
    • Editorial
    • Literature Review
    • Research Article
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:55662/feed
P-ISSN 3069-8456
E-ISSN 3069-8464
Literature Review
Vol. 7, 2023November 06, 2023 EDT

Therapeutic Advantages of Mirogabalin and Pregabalin Over Current Treatments for Chemotherapy-Induced Peripheral Neuropathy

Shannon E. Harmon, Esther O. Maidoh, Emmanuel C. Megafu, Elisabeth Point Du Jour,
literature reviewpharmacologypregabalinmirogabalinCIPNchemotherapy
https://doi.org/10.64057/001c.141911
Photo by Annie Spratt on Unsplash
SCRIP
Harmon, Shannon E., Esther O. Maidoh, Emmanuel C. Megafu, and Elisabeth Point Du Jour. 2023. “Therapeutic Advantages of Mirogabalin and Pregabalin Over Current Treatments for Chemotherapy-Induced Peripheral Neuropathy.” Scholarly Research In Progress 7 (November):107–14. https:/​/​doi.org/​10.64057/​001c.141911.

View more stats

Powered by Scholastica, the modern academic journal management system